Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Areas with lower population density have not seen the same slowdown as urban areas.
If passed, the law would boost liver disease research and create a national strategy to tackle non-alcoholic steatohepatitis.
All-cause mortality rates were highest among those with NAFLD-related cirrhosis.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
The best-performing combo, firsocostat and cilofexor, showed benefits despite missing the main study endpoint.
In mice, excessive fructose can lead to a leaky gut and trigger liver inflammation.
The experimental drug led to significant reduction in body weight but was accompanied by nausea and vomiting.
The prevalence of abnormal liver tests in people hospitalized with COVID-19 is higher than previously found.
A look at 3 forms of fatty liver disease: Non-Alcoholic Fatty Liver, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
As with HIV-negative individuals, non-alcoholic fatty liver disease is tied to diabetes and irregular blood lipids in those with HIV.
The prevalence of the condition varied depending on the age, sex and race or ethnicity of the population.
Exercising for a longer period of time was especially linked to a reduced risk of death from cardiovascular conditions.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.